Drugs / 2LALERG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02690935 | Mar 2016 → Apr 2017 | seasonal allergic rhinitis | Labo'Life | Completed | Missed primary |
Press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2026-07-01 | Labo'Life | Évolution de la composition du médicament 2LALERG labolife.com ↗ |
| 2026-07-01 | Labo'Life | Aktualisierung der Zusammensetzung des Arzneimittels 2LALERG labolife.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2LALERG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02690935 ↗ |
| Modality | Other / unclassified | “Homeopathic drug” NCT02690935 ↗ |